综述 |
|
|
|
|
肽核酸在病毒检测与治疗中的应用 * |
孙恒1,王婧1,曾令高2,王建华1,**() |
1 重庆大学生物工程学院 重庆 400044 2 重庆市食品药品检验检测研究院 重庆 401121 |
|
Application of Peptide Nucleic Acid in Virus Detection and Therapy |
SUN Heng1,WANG Jing1,ZENG Ling-gao2,WANG Jian-hua1,**() |
1 Bioengineering College of Chongqing University, Chongqing 400044, China 2 Chongqing Institute for Food and Drug Control, Chongqing 401121, China |
引用本文:
孙恒,王婧,曾令高,王建华. 肽核酸在病毒检测与治疗中的应用 *[J]. 中国生物工程杂志, 2020, 40(1-2): 146-153.
SUN Heng,WANG Jing,ZENG Ling-gao,WANG Jian-hua. Application of Peptide Nucleic Acid in Virus Detection and Therapy. China Biotechnology, 2020, 40(1-2): 146-153.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.1905007
或
https://manu60.magtech.com.cn/biotech/CN/Y2020/V40/I1-2/146
|
[1] |
Gupta A, Mishra A, Puri N . Peptide nucleic acids: Advanced tools for biomedical applications. Journal of Biotechnology, 2017,259:148-159.
|
[2] |
曾芳, 王建华, 刘春冬 . 修饰性肽核酸的合成研究进展. 中国药学杂志, 2015,50(22):1936-1945.
|
|
Zeng F, Wang J H, Liu C D . Progress of synthesis of modified peptide nucleic acid. Chin Pharm, 2015,50(22):1936-1945.
|
[3] |
刘春冬, 王建华, 曾芳 . 修饰性肽核酸的细胞转运. 生物工程学报, 2016,32(3):292-305.
|
|
Liu C D, Wang J H, Zeng F . Cellular delivery of modified peptide nucleic acids: a review. Chinese Journal of Biotechnology, 2016,32(3):292-305.
|
[4] |
Nielsen P E, Egholm M, Berg R H , et al. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science, 1991,254(5037):1497-1500.
|
[5] |
Egholm M, Buchardt O, Christensen L , et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature, 1993,365(6446):566-568.
|
[6] |
Dean D A . Peptide nucleic acids: versatile tools for gene therapy strategies. Advanced Drug Delivery Reviews, 2000,44(2):81-95.
|
[7] |
Sharma C, Awasthi S K . Versatility of peptide nucleic acids (PNAs): role in chemical biology, drug discovery and origins of life. Chemical Biology & Drug Design, 2016,89(1):16-37.
|
[8] |
Demidov V V, Potaman V N, Frank-Kamenetskii M D , et al. Stability of peptide nucleic acids in human serum and cellular extracts. Biochemical Pharmacology, 1994,48(6):1310-1313.
|
[9] |
Quijano E, Bahal R, Ricciardi A , et al. Therapeutic peptide nucleic acids: principles, limitations, and opportunities. Yale Journal of Biology & Medicine, 2017,90(4):583-598.
|
[10] |
Liu C D, Wang J H, Huang S , et al. Self-assembled nanoparticles for cellular delivery of peptide nucleic acid using amphiphilic N,N,N-trimethyl-O-alkyl chitosan derivatives. Journal of Materials Science Materials in Medicine, 2018,29:114.
|
[11] |
Shuhei H, Yoichi Y, Shigeru Y , et al. Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acids. Journal of Clinical Microbiology, 2010,48(12):4487-4494.
|
[12] |
Jang H, Kim J, Choi J J , et al. Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance. Journal of Clinical Microbiology, 2010,48(9):3127-3131.
|
[13] |
Choi Y J, Hong S K, Lee S H , et al. Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance. Archives of Virology, 2011,156(9):1517-1524.
|
[14] |
Yao C Y, Zhu T Y, Tang J , et al. Hybridization assay of hepatitis B virus by QCM peptide nucleic acid biosensor. Biosensors & Bioelectronics, 2008,23(6):879-885.
|
[15] |
Pournaghi-Azar M H, Ahour F, Hejazi M S . Direct detection and discrimination of double-stranded oligonucleotide corresponding to hepatitis C virus genotype 3a using an electrochemical DNA biosensor based on peptide nucleic acid and double-stranded DNA hybridization. Analytical & Bioanalytical Chemistry, 2010,397(8):3581-3587.
|
[16] |
Ahour F, Pournaghi-Azar M H, Alipour E , et al. Detection and discrimination of recombinant plasmid encoding hepatitis C virus core/E1 gene based on PNA and double-stranded DNA hybridization. Biosensors & Bioelectronics, 2013,45:287-291.
|
[17] |
Tsao K C, Chiou C C, Chen T L , et al. Detection of low copies of drug-resistant influenza viral gene by a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe. J Microbiol Immunol Infect, 2014,47(3):254-256.
|
[18] |
Kaihatsu K, Sawada S, Nakamura S , et al. Sequence-specific and visual identification of the influenza virus NS gene by azobenzene-tethered bis-peptide nucleic acid. PLoS One, 2013,8(5):e64017.
|
[19] |
Murakami T, Hagiwara T, Yamamoto K , et al. A novel method for detecting HIV-1 by non-radioactive in situ hybridization: application of a peptide nucleic acid probe and catalysed signal amplification. Journal of Pathology, 2001,194(1):130-135.
|
[20] |
Zhao C, Hoppe T, Setty M K H G , et al. Quantification of plasma HIV RNA using chemically engineered peptide nucleic acids. Nature Communications, 2014,5(4):5079.
|
[21] |
Ndeboko B, Lemamy G J, Nielsen P E , et al. Therapeutic potential of cell penetrating peptides (CPPs) and cationic polymers for chronic hepatitis B. International Journal of Molecular Sciences, 2015,16(12):28230-28241.
|
[22] |
Robaczewska M, Narayan R, Seigneres B , et al. Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA). Journal of Hepatology, 2005,42(2):180-187.
|
[23] |
Koppelhus U, Shiraishi T, Zachar V , et al. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid(CatLip)domain. Bioconjugate Chemistry, 2008,19(8):1526-1534.
|
[24] |
Abdul F, Ndeboko B, Buronfosse T , et al. Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide. PLoS One, 2012,7(11):e48721.
|
[25] |
Ndeboko B, Ramamurthy N, Lemamy G J , et al. Role of cell-penetrating peptides in intracellular delivery of peptide nucleic acids targeting hepadnaviral replication. Mol Ther Nucleic Acids, 2017,9:162-169.
|
[26] |
Ren X D, Nie H, Guo J T . HBV drug resistance development, testing, and prevention. Current Hepatitis Reports, 2010,9(4):223-230.
|
[27] |
Zeng Z, Han S S, Hong W , et al. A Tat-conjugated peptide nucleic acid Tat-PNA-DR Inhibits hepatitis B virus replication in vitro and in vivo by targeting LTR direct repeats of HBV RNA. Molecular Therapy Nucleic Acids, 2016,5(3):e295.
|
[28] |
Zhao X L, Chen B C, Han J C , et al. Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold. Scientific Reports, 2015,5:17640.
|
[29] |
Al-Harbi R A K, Abdel-Rahman A H . Synthesis and anti-hepatitis B virus activity of new pyrimidine peptide nucleic acid analogs. Chemistry of Heterocyclic Compounds, 2012,47(10):1290-1297.
|
[30] |
Nulf C J, Corey D . Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs). Nucleic Acids Research, 2004,32(13):3792-3798.
|
[31] |
Alotte C, Martin A, Caldarelli S A , et al. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro. Antiviral Research, 2008,80(3):280-287.
|
[32] |
Ahn D G, Shim S B, Moon J E , et al. Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA. Journal of Viral Hepatitis, 2011,18(7):e298-e306.
|
[33] |
Friedland B . In vitro antiviral activity of a peptide-nucleic acid solution against the human immunodeficiency virus and influenza A virus. Journal of the Royal Society of Health, 1991,111(5):170-171.
|
[34] |
Kesy J, Patil K M, Kumar S R , et al. A short chemically modified dsRNA-binding PNA (dbPNA) inhibits influenza viral replication by targeting viral RNA panhandle structure. Bioconjugate Chemistry, 2019,30(3):931-943.
|
[35] |
Amirkhanov R N, Mazurkova N A, Amirkhanov N V , et al. Composites of peptide nucleic acids with titanium dioxide nanoparticles. IV. Antiviral activity of nanocomposites containing DNA/PNA duplexes. Russian Journal of Bioorganic Chemistry, 2015,41(2):140-146.
|
[36] |
Pandey V N, Upadhyay A, Chaubey B . Prospects for antisense peptide nucleic acid (PNA) therapies for HIV. Expert Opin Biol Ther, 2009,9(8):975-989.
|
[37] |
Chaubey B, Tripathi S, Pandey V N . Single acute-dose and repeat-doses toxicity of anti-HIV-1 PNA TAR-penetratin conjugate after intraperitoneal administration to mice. Oligonucleotides, 2008,18(1):9-20.
|
[38] |
Upadhyay A, Ponzio N M, Pandey V N . Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome. Oligonucleotides, 2008,18(4):329-335.
|
[39] |
Das I, Désiré J, Manvar D , et al. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription. Journal of Medicinal Chemistry, 2012,55(13):6021-6032.
|
[40] |
Yoo J S, Kim C M, Kim J H , et al. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA. Antiviral Research, 2009,82(3):122-133.
|
[41] |
Ahn D G, Lee W, Choi J K , et al. Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication. Antiviral Res, 2011,91(1):1-10.
|
[42] |
王建华, 郭泽琴 . 肽核酸在分子生物学技术中的应用. 中国生物工程杂志, 2013,33(01):90-94.
|
|
Wang J H, Guo Z Q . Application of peptide nucleic acid in molecular biotechnology. China Biotechnology, 2013,33(1):90-94.
|
[43] |
Liu C D, Wang J H, Xie Y , et al. Synthesis and DNA/RNA complementation studies of peptide nucleic acids containing 5-halouracils. Medchemcomm, 2016,8(2):385-389.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|